119 related articles for article (PubMed ID: 37625845)
1. Suppression of Autophagy Can Augment PIK3 Inhibitor Induced Apoptosis in T Lymphoblastic Leukemia Cell Lines.
Dong YQ; Sun N; Yang XC; He MQ; Huang H; Guo WJ; Lin XJ
Ann Clin Lab Sci; 2023 Jul; 53(4):598-606. PubMed ID: 37625845
[TBL] [Abstract][Full Text] [Related]
2. The role and mechanism of AZD5363 anti-leukemia activity in T-cell acute lymphoblastic leukemia.
Luo D; Li S; Guo J; Yue H; Shi L; Liu R; Wang J; Shi X
Eur J Pharmacol; 2024 Jan; 963():176268. PubMed ID: 38096965
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of FAPP2 gene induces cell autophagy and inhibits PI3K/AKT/mTOR pathway in T-cell acute lymphoblastic leukemia.
Yuan T; Wang J; Shi C; Wang Y; Xia B; Xu W; Yang H; Yang Y; Ye MT; Khalid S; Liang Y; Tian C; You MJ; Wang Y
Hematol Oncol; 2022 Apr; 40(2):249-257. PubMed ID: 34796518
[TBL] [Abstract][Full Text] [Related]
4. Resveratrol induces apoptosis and autophagy in T-cell acute lymphoblastic leukemia cells by inhibiting Akt/mTOR and activating p38-MAPK.
Ge J; Liu Y; Li Q; Guo X; Gu L; Ma ZG; Zhu YP
Biomed Environ Sci; 2013 Nov; 26(11):902-11. PubMed ID: 24331535
[TBL] [Abstract][Full Text] [Related]
5. Healthy CD4+ T lymphocytes are not affected by targeted therapies against the PI3K/Akt/mTOR pathway in T-cell acute lymphoblastic leukemia.
Alameen AA; Simioni C; Martelli AM; Zauli G; Ultimo S; McCubrey JA; Gonelli A; Marisi G; Ulivi P; Capitani S; Neri LM
Oncotarget; 2016 Aug; 7(34):55690-55703. PubMed ID: 27494886
[TBL] [Abstract][Full Text] [Related]
6. The depletion of Circ-PRKDC enhances autophagy and apoptosis in T-cell acute lymphoblastic leukemia via microRNA-653-5p/Reelin mediation of the PI3K/AKT/mTOR signaling pathway.
Ling Z; Fang ZG; Wu JY; Liu JJ
Kaohsiung J Med Sci; 2021 May; 37(5):392-401. PubMed ID: 33615686
[TBL] [Abstract][Full Text] [Related]
7. [Effects of Thiomersal on Apoptosis and Autophagy of Leukemia Cell Lines].
Wang Y; Yao H; Li ZL; Yang K; Bai H
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Dec; 30(6):1655-1660. PubMed ID: 36476885
[TBL] [Abstract][Full Text] [Related]
8. Timosaponin A‑III induces autophagy of T‑cell acute lymphoblastic leukemia Jurkat cells via inhibition of the PI3K/Akt/mTOR pathway.
Wang H; Dong R; Fan WW; Zheng XC; Li AM; Wang WD
Oncol Rep; 2019 May; 41(5):2937-2944. PubMed ID: 30896824
[TBL] [Abstract][Full Text] [Related]
9. PI3K pan-inhibition impairs more efficiently proliferation and survival of T-cell acute lymphoblastic leukemia cell lines when compared to isoform-selective PI3K inhibitors.
Lonetti A; Cappellini A; Spartà AM; Chiarini F; Buontempo F; Evangelisti C; Evangelisti C; Orsini E; McCubrey JA; Martelli AM
Oncotarget; 2015 Apr; 6(12):10399-414. PubMed ID: 25871383
[TBL] [Abstract][Full Text] [Related]
10. Improving nelarabine efficacy in T cell acute lymphoblastic leukemia by targeting aberrant PI3K/AKT/mTOR signaling pathway.
Lonetti A; Cappellini A; Bertaina A; Locatelli F; Pession A; Buontempo F; Evangelisti C; Evangelisti C; Orsini E; Zambonin L; Neri LM; Martelli AM; Chiarini F
J Hematol Oncol; 2016 Oct; 9(1):114. PubMed ID: 27776559
[TBL] [Abstract][Full Text] [Related]
11. Molecular effects of the phosphatidylinositol-3-kinase inhibitor NVP-BKM120 on T and B-cell acute lymphoblastic leukaemia.
Pereira JK; Machado-Neto JA; Lopes MR; Morini BC; Traina F; Costa FF; Saad ST; Favaro P
Eur J Cancer; 2015 Sep; 51(14):2076-85. PubMed ID: 26238016
[TBL] [Abstract][Full Text] [Related]
12. Marsdenia tenacissimae extraction (MTE) inhibits the proliferation and induces the apoptosis of human acute T cell leukemia cells through inactivating PI3K/AKT/mTOR signaling pathway via PTEN enhancement.
Wang Y; Chen B; Wang Z; Zhang W; Hao K; Chen Y; Li K; Wang T; Xie Y; Huang Z; Tong X
Oncotarget; 2016 Dec; 7(50):82851-82863. PubMed ID: 27756877
[TBL] [Abstract][Full Text] [Related]
13. Activity of the novel dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor NVP-BEZ235 against T-cell acute lymphoblastic leukemia.
Chiarini F; Grimaldi C; Ricci F; Tazzari PL; Evangelisti C; Ognibene A; Battistelli M; Falcieri E; Melchionda F; Pession A; Pagliaro P; McCubrey JA; Martelli AM
Cancer Res; 2010 Oct; 70(20):8097-107. PubMed ID: 20876803
[TBL] [Abstract][Full Text] [Related]
14. Andrographolide inhibits growth of human T-cell acute lymphoblastic leukemia Jurkat cells by downregulation of PI3K/AKT and upregulation of p38 MAPK pathways.
Yang T; Yao S; Zhang X; Guo Y
Drug Des Devel Ther; 2016; 10():1389-97. PubMed ID: 27114702
[TBL] [Abstract][Full Text] [Related]
15. Autophagy inhibitor potentiates the antitumor efficacy of apatinib in uterine sarcoma by stimulating PI3K/Akt/mTOR pathway.
Chen S; Yao L
Cancer Chemother Pharmacol; 2021 Aug; 88(2):323-334. PubMed ID: 33978839
[TBL] [Abstract][Full Text] [Related]
16. Triple Akt inhibition as a new therapeutic strategy in T-cell acute lymphoblastic leukemia.
Cani A; Simioni C; Martelli AM; Zauli G; Tabellini G; Ultimo S; McCubrey JA; Capitani S; Neri LM
Oncotarget; 2015 Mar; 6(9):6597-610. PubMed ID: 25788264
[TBL] [Abstract][Full Text] [Related]
17. [Electroacupuncture promotes gastrointestinal motility by activating autophagy of Cajal interstitial cells via downregulating PI3K/Akt/mTOR signaling pathway in stomach of diabetic gastro-paresis rats].
Zhang TH; Zhao ST; Li XY; Xiao XJ; Xiao L; Wei X; Peng Y
Zhen Ci Yan Jiu; 2022 Dec; 47(12):1060-7. PubMed ID: 36571220
[TBL] [Abstract][Full Text] [Related]
18. Procyanidins, from Castanea mollissima Bl. shell, induces autophagy following apoptosis associated with PI3K/AKT/mTOR inhibition in HepG2 cells.
Zhang H; Luo X; Ke J; Duan Y; He Y; Zhang D; Cai M; Sun G; Sun X
Biomed Pharmacother; 2016 Jul; 81():15-24. PubMed ID: 27261572
[TBL] [Abstract][Full Text] [Related]
19. 3-MA Enhanced Chemosensitivity in Cisplatin Resistant Hypopharyngeal Squamous Carcinoma Cells via Inhibiting Beclin -1 Mediated Autophagy.
Zhang J; Mao W; Liu Y; Ding J; Wang J; Yu Z; Huang R; Yang S; Sun Y; Dong P
Curr Pharm Des; 2021; 27(7):996-1005. PubMed ID: 33349212
[TBL] [Abstract][Full Text] [Related]
20. Novel Compound, ND-17, Regulates the JAK/STAT, PI3K/AKT, and MAPK Pathways and Restrains Human T-lymphoid Leukemia Development.
Ma W; Liu Y; Lei P; Zhu M; Pan X
Curr Cancer Drug Targets; 2022; 22(5):404-413. PubMed ID: 35249489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]